Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jessica Joyce

Physician Assistant Glen Allen, VA Physician Assistant

NPI 1992168850 CMS profile 11148406

5201 Hickory Park Dr Ste A, Glen Allen, VA 23058

Open in the dashboard

General payments

$8,906

419 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jessica Joyce of Glen Allen, VA is reported in the CMS Open Payments database as having received $8,906 across 419 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,266 110
2024 General $1,820 95
2023 General $1,748 86
2022 General $1,651 75
2021 General $1,421 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jessica Joyce
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Jessica Joyce were reported at $2,266. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Jessica Joyce Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,421 $132 $37–$438 $132
2022 $1,651 $155 $48–$522 $149
2023 $1,748 $167 $52–$557 $160
2024 $1,820 $178 $55–$600 $164
2025 $2,266 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Biotech, Inc. $2,511 129 payments
  2. AbbVie, Inc. $1,039 58 payments
  3. Incyte Corporation $1,038 39 payments
  4. Regeneron Healthcare Solutions, Inc. $489 15 payments
  5. Genzyme Corporation $451 13 payments
  6. Sun Pharmaceutical Industries Inc. $432 21 payments
  7. Novartis Pharmaceuticals Corporation $400 19 payments
  8. Lilly USA, LLC $359 12 payments
  9. Pfizer Inc. $348 14 payments
  10. Dermavant Sciences, Inc. $320 33 payments
  11. Other $1,518 66 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,377 412 payments
  2. Education $529 7 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $2,333 119 payments
  2. OPZELURA $919 38 payments
  3. DUPIXENT Immunology $665 19 payments
  4. SKYRIZI $622 30 payments
  5. VTAMA $516 37 payments
  6. DUPIXENT Inflammation And Immunology $372 10 payments
  7. EUCRISA $331 13 payments
  8. CIBINQO $230 9 payments
  9. Winlevi $228 11 payments
  10. TALTZ $213 10 payments
  11. Other $3,871 200 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

654

Median for Physician Assistant: 241

Drug cost

$20,656

Median for Physician Assistant: $4,110

Branded share of claims

16.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clobetasol Propionate Generic 116 $6,500
Tacrolimus Generic 31 $4,051
Ketoconazole Generic 131 $2,382
Triamcinolone Acetonide Generic 119 $1,097
Fluorouracil Generic 14 $1,070
Ciclopirox Ciclopirox Olamine Brand 46 $1,021
Metronidazole Generic 15 $829
Desonide Generic 18 $721
Clindamycin Phosphate Generic 13 $644
Betamethasone Diprop Augmented Betamethasone/Propylene Glyc Brand 43 $611

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$89,704

Of which drugs: $6,627

Medicare patients

675

Average age 75

Services billed

2,287

352 women, 323 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 42%
Diabetes 25%
Ischemic heart disease 23%
Chronic kidney disease 18%
Depression 18%
Cancer 16%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) J7308 Office 20 24 $6,610
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 13 23 $17

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 17 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TREMFYA
  • Janssen Biotech, Inc. $716
$716 — —
DUPIXENT
  • GENZYME CORPORATION $172
  • Regeneron Healthcare Solutions, Inc. $87
$259 — —
OPZELURA
  • Incyte Corporation $177
$177 — —
VTAMA
  • Dermavant Sciences, Inc. $167
$167 — —
SKYRIZI
  • AbbVie, Inc. $140
$140 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 17 in the dashboard with a free account

Records

419 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record